login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CENTURY THERAPEUTICS INC (IPSC) Stock News
USA
- NASDAQ:IPSC -
US15673T1007
-
Common Stock
0.4645
USD
-0.1 (-17.54%)
Last: 11/13/2025, 8:00:02 PM
0.47
USD
+0.01 (+1.18%)
Pre-Market:
11/14/2025, 9:00:30 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IPSC Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
a day ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
a day ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
a day ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
3 months ago - By: The Motley Fool
Century Reports Flat Loss in Fiscal Q2
8 months ago - By: Benzinga
Demystifying Century Therapeutics: Insights From 4 Analyst Reviews
a month ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
a month ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
3 months ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
10 months ago - By: Benzinga
4 Analysts Have This To Say About Century Therapeutics
3 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
5 months ago - By: Zacks Investment Research
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
6 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
6 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
6 months ago - By: Zacks Investment Research
- Mentions:
MDT
Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
6 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
6 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
6 months ago - By: Zacks Investment Research
- Mentions:
DERM
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
VRCA
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
7 months ago - By: Zacks Investment Research
Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
7 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
7 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
7 months ago - By: Century Therapeutics, Inc.
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
7 months ago - By: Century Therapeutics, Inc.
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
8 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
8 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
10 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
10 months ago - By: Century Therapeutics, Inc.
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
a year ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
a year ago - By: Century Therapeutics, Inc.
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
a year ago - By: Century Therapeutics, Inc.
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Please enable JavaScript to continue using this application.